TXP Medical Transitions to an AI-Native Company — Deploying Claude to All Full-Time Employees
TXP Medical Co., Ltd. announced in April 2026 that it has begun a company-wide transition to AI-native business operations by deploying Anthropic's generative AI "Claude" to all full-time employees. This initiative positions AI as a core management infrastructure to exponentially enhance organizational decision-making speed and execution capabilities.
📋 Article Processing Timeline
- 📰 Published: April 30, 2026 at 18:00
- 🔍 Collected: April 30, 2026 at 09:31
- 🤖 AI Analyzed: April 30, 2026 at 09:37 (5 min after Collected)
TXP Medical Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; Representative Director CEO: Tomohiro Sonoo) announced in April 2026 that it has begun a company-wide transition to AI-native (AI-first) business operations by deploying Anthropic's generative AI "Claude" to all full-time employees.
■ "Proficiency in AI is a prerequisite," not "AI can be used."
We position AI not as a convenient business tool, but as a management infrastructure to exponentially expand the organization's decision-making speed and execution capabilities. Instead of only some specialists interacting with AI, we are redesigning operations and the organization on the premise that all job functions—doctors, engineers, sales, and corporate staff—will routinely master AI.
We are also focusing on developing AI-native talent, positioning the redefinition of daily tasks with rich ideas, based on the premise of AI utilization by all employees, as a key evaluation item in personnel assessments.
■ Commitment to an AI-native culture
For us, the transition to AI-native is not limited to improving operational efficiency and productivity. It is an attempt to rewrite the organization's OS itself. Our approach is to redesign all company operations—information gathering, organizational decision-making, product development, operational support for the field, back-office tasks—on the premise of collaboration with AI.
【Comment from Representative Director CEO Tomohiro Sonoo】
"As a company that provides services supporting medical frontline, innovation in our business structure through AI utilization is positioned as an extremely important management theme. How far we can leverage AI as a company's weapon, riding the wave of AI utilization, will be a core factor determining our competitiveness in the coming years. With the introduction of Claude to all employees as a starting point, TXP Medical aims to be reborn as an AI-native company and further contribute to medicine."
Moving forward, TXP Medical will continue to promote the utilization of medical data and work towards realizing its mission of "saving lives with medical data" through technology development rooted in the field and strengthening organizational capabilities.
【TXP Medical Business Overview】
TXP Medical is a startup leading the next-generation medical infrastructure, founded by an active emergency and critical care physician, with the mission to "save lives with medical data." Its core system, NEXT Stage ER, is operational in over 100 major hospitals nationwide (approximately 50% share in university hospitals and emergency medical centers), and NSER mobile for emergency services has operational実績 in 51 regions nationwide, covering a population of over 12 million people.
Representative Director: Tomohiro Sonoo (Emergency and Critical Care Physician)
Established: August 28, 2017
HP: https://txpmedical.jp/
Development and provision of "NEXT Stage series" acute care medical data platforms for medical institutions and local governments
Development and provision of acute care medical AI technology, clinical research support business
Unique real-world data service in the acute care domain utilizing over 900 items of test data, vital data, etc.
■ "Proficiency in AI is a prerequisite," not "AI can be used."
We position AI not as a convenient business tool, but as a management infrastructure to exponentially expand the organization's decision-making speed and execution capabilities. Instead of only some specialists interacting with AI, we are redesigning operations and the organization on the premise that all job functions—doctors, engineers, sales, and corporate staff—will routinely master AI.
We are also focusing on developing AI-native talent, positioning the redefinition of daily tasks with rich ideas, based on the premise of AI utilization by all employees, as a key evaluation item in personnel assessments.
■ Commitment to an AI-native culture
For us, the transition to AI-native is not limited to improving operational efficiency and productivity. It is an attempt to rewrite the organization's OS itself. Our approach is to redesign all company operations—information gathering, organizational decision-making, product development, operational support for the field, back-office tasks—on the premise of collaboration with AI.
【Comment from Representative Director CEO Tomohiro Sonoo】
"As a company that provides services supporting medical frontline, innovation in our business structure through AI utilization is positioned as an extremely important management theme. How far we can leverage AI as a company's weapon, riding the wave of AI utilization, will be a core factor determining our competitiveness in the coming years. With the introduction of Claude to all employees as a starting point, TXP Medical aims to be reborn as an AI-native company and further contribute to medicine."
Moving forward, TXP Medical will continue to promote the utilization of medical data and work towards realizing its mission of "saving lives with medical data" through technology development rooted in the field and strengthening organizational capabilities.
【TXP Medical Business Overview】
TXP Medical is a startup leading the next-generation medical infrastructure, founded by an active emergency and critical care physician, with the mission to "save lives with medical data." Its core system, NEXT Stage ER, is operational in over 100 major hospitals nationwide (approximately 50% share in university hospitals and emergency medical centers), and NSER mobile for emergency services has operational実績 in 51 regions nationwide, covering a population of over 12 million people.
Representative Director: Tomohiro Sonoo (Emergency and Critical Care Physician)
Established: August 28, 2017
HP: https://txpmedical.jp/
Development and provision of "NEXT Stage series" acute care medical data platforms for medical institutions and local governments
Development and provision of acute care medical AI technology, clinical research support business
Unique real-world data service in the acute care domain utilizing over 900 items of test data, vital data, etc.